Insights

Loading spinner
Gathering insights about Cerevel Therapeutics

Cerevel Therapeutics Tech Stack

Cerevel Therapeutics uses 8 technology products and services including Nitro, Google Cloud, Office 365, and more. Explore Cerevel Therapeutics's tech stack below.

  • Nitro
    Electronic Signatures
  • Google Cloud
    Infrastructure As A Service
  • Office 365
    Office Suites
  • LinkedIn
    Online Community Software
  • WP Engine
    Platform As A Service
  • Smartsheet
    Project Management
  • EndNote
    Team Collaboration
  • Google Analytics
    Web Analytics

Media & News

Cerevel Therapeutics's Email Address Formats

Cerevel Therapeutics uses at least 1 format(s):
Cerevel Therapeutics Email FormatsExamplePercentage
First.Last@cerevel.comJohn.Doe@cerevel.com
98%
First.L@cerevel.comJohn.D@cerevel.com
2%

Frequently Asked Questions

Where is Cerevel Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Cerevel Therapeutics's main headquarters is located at 1 N Waukegan Rd North Chicago, Illinois 60064 US. The company has employees across 2 continents, including North AmericaEurope.

What is Cerevel Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Cerevel Therapeutics is a publicly traded company; the company's stock symbol is CERE.

What is Cerevel Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Cerevel Therapeutics's official website is cerevel.com and has social profiles on LinkedIn.

How much revenue does Cerevel Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2025, Cerevel Therapeutics's annual revenue reached $501B.

What is Cerevel Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Cerevel Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cerevel Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2025, Cerevel Therapeutics has approximately 10K employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: S. Y.Chief Executive Officer: T. C.Chief Human Resources Officer: K. D.. Explore Cerevel Therapeutics's employee directory with LeadIQ.

What industry does Cerevel Therapeutics belong to?

Minus sign iconPlus sign icon
Cerevel Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Cerevel Therapeutics use?

Minus sign iconPlus sign icon
Cerevel Therapeutics's tech stack includes NitroGoogle CloudOffice 365LinkedInWP EngineSmartsheetEndNoteGoogle Analytics.

What is Cerevel Therapeutics's email format?

Minus sign iconPlus sign icon
Cerevel Therapeutics's email format typically follows the pattern of . Find more Cerevel Therapeutics email formats with LeadIQ.

How much funding has Cerevel Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2025, Cerevel Therapeutics has raised $450M in funding. The last funding round occurred on Oct 11, 2023 for $450M.
Cerevel Therapeutics

Cerevel Therapeutics

Pharmaceutical ManufacturingIllinois, United States10001+ Employees

Cerevel is now part of AbbVie. 

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.  

For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.

Section iconCompany Overview

Headquarters
1 N Waukegan Rd North Chicago, Illinois 60064 US
Stock Symbol
CERE
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
10001+

Section iconFunding & Financials

  • $450M

    Cerevel Therapeutics has raised a total of $450M of funding over 6 rounds. Their latest funding round was raised on Oct 11, 2023 in the amount of $450M.

  • $1B

    Cerevel Therapeutics's revenue is in the range of $1B

Section iconFunding & Financials

  • $450M

    Cerevel Therapeutics has raised a total of $450M of funding over 6 rounds. Their latest funding round was raised on Oct 11, 2023 in the amount of $450M.

  • $1B

    Cerevel Therapeutics's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.